LekoskopLekoskop
UK · ES · FR · CS · IT · NL · CH · HR · PL

New approvals — United Kingdom

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 27 Sep 2026 13:39.

All Recalls and defects2 Serious shortages (SSP)2 New approvals1 Drug Safety Update1

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

23 Sep 2026Wednesday 23 September 2026 · 4 days ago

open day ◀ ▶ 1 event
MHRA approval lurbinectedin
As with all licensed medicines, the MHRA will keep the safety and effectiveness of lurbinectedin under close review.
What this means, batches, details

Loading…

6 Aug 2026Thursday 6 August 2026

open day ◀ ▶ 1 event
MHRA approval remibrutinib
As with any medicinal product, the MHRA will keep the safety and effectiveness of remibrutinib under close review.  
What this means, batches, details

Loading…

21 Jul 2026Tuesday 21 July 2026

open day ◀ ▶ 1 event
The new inhalers use a next-generation propellant designed to reduce environmental impact while maintaining the same established treatment.
What this means, batches, details

Loading…

6 Jul 2026Monday 6 July 2026

open day ◀ ▶ 1 event
MHRA approval Retifanlimab (ZYNYZ)
Merkel cell carcinoma (MCC) is a rare and aggressive type of skin cancer that develops from Merkel cells, specialised neuroendocrine cells found in the top layer of the skin.  
What this means, batches, details

Loading…

1 Jul 2026Wednesday 1 July 2026

open day ◀ ▶ 1 event
As with any medicinal product, the MHRA will keep the safety and effectiveness of the intravesical delivery system containing gemcitabine under close review.  
What this means, batches, details

Loading…

In total 34 events in this category.